Potential role of primary hypercoagulability and antiphospholipid antibody as a risk factor of acute pulmonary thromboembolism

Journal of Cardiology

Volumn 32, Issue 4, 1998, Pages 263-268

  Tokuyama, K ^a   Kiuchi, K ^a   Nejima, J ^a   Takayama, M ^a   Takano, T ^a   Hayakawa, H ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Anticoagulants; Protein C and S deficiencies; Pulmonary embolism; Thromboembolism; Thrombosis (deep vein)

Indexed keywords

CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; HYPERCOAGULABILITY; LUNG EMBOLISM; MALE; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; RISK ASSESSMENT; THROMBOEMBOLISM;

ACUTE DISEASE; ADULT; AGED; ANTIBODIES, ANTIPHOSPHOLIPID; FEMALE; HUMANS; LUPUS COAGULATION INHIBITOR; MALE; MIDDLE AGED; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; PULMONARY EMBOLISM; RISK FACTORS; THROMBOPHILIA;

EID: 0031767334     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)